Buscar resultados de ensayos clínicos
Cutaneous T-cell Lymphoma - 27 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma Condición: Cutaneous T Cell Lymphoma Fecha: 2010-05-25 Intervenciones: Drug: Lenalidomide Lenalidomide Starting Dose Based on Renal Function at Study Entry Baseline Calculated |
Recruiting |
Nombre del estudio: Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) Condición: Cutaneous T Cell Lymphoma Fecha: 2014-07-10 Intervenciones: Drug: Micro needle array-Doxorubicin (MNA-D) MNA-D patches will be applied to 3-4 CTCL skin patches or p |
Completed |
Nombre del estudio: Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2007-01-22 Intervenciones: Drug: Panobinostat Other Name: LBH589 |
Terminated |
Nombre del estudio: Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2009-02-24 Intervenciones: Procedure: skin biopsy Lidocaine 1% c Epinephrine for local anesthesia |
Withdrawn |
Nombre del estudio: Trial of Curcumin in Cutaneous T-cell Lymphoma Patients Condición: Cutaneous T-cell Lymphoma Fecha: 2009-08-27 Intervenciones:
|
Completed |
Nombre del estudio: A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma Condición: Cutaneous T-cell Lymphoma Fecha: 2007-02-05 Intervenciones: Drug: APO866 APO866 is administered as 0.126 mg/m²/hr for 4 consecutive days (96 hours), every 3 we |
Completed |
Nombre del estudio: Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2007-06-21 Intervenciones: Drug: LBH589 Other Name: panobinostat |
Completed |
Nombre del estudio: Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma Condición: Cutaneous T-cell Lymphoma Fecha: 2007-11-05 Intervenciones:
|
Terminated |
Nombre del estudio: Everolimus in Treating Cutaneous T-cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2012-04-02 Intervenciones: Drug: Everolimus The study drug everolimus will be self-ad |
Recruiting |
Nombre del estudio: A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma Condición: Persistent or Recurrent Cutaneous T-Cell Lymphoma Fecha: 2013-03-28 Intervenciones: Drug: E7777 administered by intravenous (i.v.) infusion over 60 minutes (+/-10 minutes) on 5 consecutive |